drugset / Trial / NCT06354556

Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects

NCT06354556

Phase 1 Completed 14 enrolled Shandong Suncadia Medicine Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this phase Ⅰ study is to evaluate the effect of oral verapamil tablets on the pharmacokinetics of HRS-1893 in healthy subjects.

Timeline

Start
2024-04-26
Primary completion
2024-05-20
Completion
2024-05-20

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS-1893 Unknown
Subject Verapamil Other / unclassified 80 mg Oral